p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a

Nature

Volumn 448, Issue 7156, 2007, Pages 943-946

  Krimpenfort, Paul ^a   IJpenberg, Annemieke ^a,b   Song, Ji Ying ^a   Van Der Valk, Martin ^a   Nawijn, Martijn ^a   Zevenhoven, John ^a   Berns, Anton ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P16INK4A; CDKN2A PROTEIN, MOUSE; CDKN2B PROTEIN, MOUSE; MESSENGER RNA; UNCLASSIFIED DRUG;

CANCER; CHROMOSOME; PROTEIN; RODENT; TUMOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; MOUSE; MUTANT; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; STRESS; ANIMAL; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION; CYTOLOGY; EMBRYO; GENE DELETION; GENETICS; HUMAN; METABOLISM; ONCOGENE; PATHOLOGY; SARCOMA; SKIN TUMOR; TUMOR SUPPRESSOR GENE;

MUS;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EMBRYO; FIBROBLASTS; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; ONCOGENES; OPEN READING FRAMES; RNA, MESSENGER; SARCOMA; SKIN NEOPLASMS;

EID: 34548176271     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06084     Document Type: Article

References (24)

1. Gil, J. & Peters, G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nature Rev. Mol. Cell Biol. 7, 667-677 (2006).
2. Ortega, S., Malumbres, M. & Barbacid, M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602, 73-87 (2002).
3. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723 (1998).
4. Drexler, H. G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 12, 845-859 (1998).
5. Krug, U., Ganser, A. & Koeffler, H. P. Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene 21, 3475-3495 (2002).
6. Murao, K., Kubo, Y., Ohtani, N., Hara, E. & Arase, S. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways. Br. J. Dermatol. 155, 999-1005 (2006).
7. Orlow, I. et al. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival. J. Natl. Cancer Inst. 91, 73-79 (1999).
8. INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378, F115-F177 (1998).
9. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37 (1996).
10. ARF. Cell 91, 649-659 (1997).
11. Kamijo, T., Bodner, S., van de Kamp, E., Randle, D. H. & Sherr, C. J. Tumor spectrum in ARF-deficient mice. Cancer Res. 59, 2217-2222 (1999).
12. Arf predisposes mice to tumorigenesis. Nature 413, 86-91 (2001).
13. Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413, 83-86 (2001).
14. Kim, W. Y. & Sharpless, N. E. The regulation of INK4/ARF in cancer and aging. Cell 127, 265-275 (2006).
15. INK4c cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19, 3496-3506 (2000).
16. Zou, X. et al. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Genes Dev. 16, 2923-2934 (2002).
17. Pantoja, C., Palmero, I. & Serrano, M. Identification of the gene immediately downstream of the murine INK4a/ARF locus. Exp. Gerontol. 36, 1289-1302 (2001).
18. ARF deficiency on cell growth and tumorigenesis. Oncogene 23, 379-385 (2004).
19. Parry, D., Mahony, D., Wills, K. & Lees, E. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol. Cell. Biol. 19, 1775-1783 (1999).
20. 3 to focal contacts. EMBO J. 18, 2106-2118 (1999).
21. Harrison, P. T. An ethanol-acetic acid-formol saline fixative for routine use with special application to the fixation of non-perfused rat lung. Lab. Anim. 18, 325-331 (1984).
22. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684 (1995).
23. Cip1 are not required for the formation of active D cyclin-cdk4 complexes. Mol. Cell. Biol. 23, 7285-7290 (2003).
24. Lyons, S. K., Meuwissen, R., Krimpenfort, P. & Berns, A. The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice. Cancer Res. 63, 7042-7046 (2003).